Human epidermal growth factor receptor 2 (HER2)–targeted therapy continues to evolve, now with antibody-drug conjugates (ADCs) such as trastuzumab ...READ MORE
Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medic...READ MORE
patient care perspectives by Michael C. Heinrich, MD
The risk of recurrence, growth, and spread of gastrointestinal stromal tumors (GIST) after surgery relates to key variables such as the size, locat......READ MORE
clinical study insights by Richard Lafayette, MD, FACP; Carla M. Nester, MD, MSA, FASN; and Jai Radhakrishnan, MD, MS
There is hope that advancements in the science of complement inhibition will allow clinicians to do more for their patients with complement-driven ...READ MORE
expert roundtables by Peter Campochiaro, MD; Peter K. Kaiser, MD; and SriniVas R. Sadda, MD, FARVO
Recent advances in retinal imaging have led to improvements in the early identification and monitoring of patients with neovascular age-related mac...READ MORE
